Log in
VTX:SREN

Swiss Re Stock Forecast, Price & News

Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume1.71 million shs
Average Volume2.14 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments. Its Corporate Solutions segment is engaged in serving mid-sized and large corporations, with product offerings ranging from traditional property and casualty insurance to customized solutions. Its Admin Re segment provides risk and capital management solutions by which the Company acquires closed books of in-force life and health insurance business, entire lines of business, or the entire capital stock of life insurance companies. Its open and closed life insurance books, including Admin Re, are managed under a unit called Life Capital.
Read More
Swiss Re logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.4Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.43 out of 5 stars


Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
Phone+41-43-2852121

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive SREN News and Ratings via Email

Sign-up to receive the latest news and ratings for SREN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Swiss Re (VTX:SREN) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Swiss Re?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Swiss Re in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Swiss Re
.

What price target have analysts set for SREN?

11 analysts have issued twelve-month price objectives for Swiss Re's stock. Their forecasts range from CHF 75 to CHF 100. On average, they expect Swiss Re's share price to reach CHF 91.80 in the next twelve months.
View analysts' price targets for Swiss Re
.

What other stocks do shareholders of Swiss Re own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Swiss Re investors own include SWISS RE LTD/S (SSREY), Intel (INTC), Skyworks Solutions (SWKS), Alcoa (AA), Abbott Laboratories (ABT), American Tower (AMT), AstraZeneca (AZN), Kraft Heinz (KHC), Mastercard (MA) and Omega Healthcare Investors (OHI).

Who are Swiss Re's key executives?

Swiss Re's management team includes the following people:
  • Christian Mumenthaler, Group Chief Executive Officer, Member of the Executive Board (Age 49)
  • David Cole, Group Chief Financial Officer, Member of the Executive Board (Age 57)
  • Jeff Summerville, Head Casualty - Financial and Professional Services North America
  • John Robert Dacey, Group Chief Financial Officer, Member of the Executive Board (Age 57)
  • Walter B. Kielholz, Non-Executive Chairman of the Board of Directors (Age 66)
  • Renato Fassbind Ph.D., Non-Executive Vice Chairman and Lead Independent Director of the Board (Age 63)
  • Raymond K. F. Ch'ien, Non-Executive Independent Member of the Board of Directors (Age 66)
  • Mary Francis, Non-Executive Independent Member of the Board of Directors (Age 70)
  • C. Robert Henrikson, Non-Executive Independent Member of the Board of Directors (Age 71)

What is Swiss Re's stock symbol?

Swiss Re trades on the VTX under the ticker symbol "SREN."

What is Swiss Re's official website?

The official website for Swiss Re is www.swissre.com.

How can I contact Swiss Re?

Swiss Re's mailing address is Mythenquai 50/60, ZUERICH, 8002, Switzerland. The company can be reached via phone at +41-43-2852121.

This page was last updated on 9/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.